{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:47:23Z","timestamp":1780710443911,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.clim.2004.04.001","type":"journal-article","created":{"date-parts":[[2004,5,31]],"date-time":"2004-05-31T15:09:05Z","timestamp":1086016145000},"page":"92-105","source":"Crossref","is-referenced-by-count":12,"title":["Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine"],"prefix":"10.1016","volume":"112","author":[{"given":"Satoshi","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Shiosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nakasatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichirou","family":"Kino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2004.04.001_BIB1","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1016\/S0021-9258(18)45212-X","article-title":"RNase H activity associated with bacterially expressed reverse transcriptase of human T-cell lymphotropic virus III\/lymphadenopathy-associated virus","volume":"262","author":"Hansen","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2004.04.001_BIB2","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JVI.69.6.3389-3398.1995","article-title":"Targeting foreign proteins to human immunodeficiency virus particles via fusion Vpr and Vpx","volume":"69","author":"Wu","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0264-410X(93)90046-Z","article-title":"Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins","volume":"11","author":"Charbit","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2004.04.001_BIB4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.clim.2004.04.001_BIB5","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.89.16.7777","article-title":"Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model","volume":"89","author":"Natuk","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB6","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1128\/JVI.73.9.7524-7532.1999","article-title":"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen","volume":"73","author":"Hanke","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0264-410X(96)00264-2","article-title":"Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit","volume":"15","author":"Barnett","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2004.04.001_BIB8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-065X.1999.tb01336.x","article-title":"Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections","volume":"170","author":"Berzofsky","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2004.04.001_BIB9","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.72.10.8264-8272.1998","article-title":"Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein","volume":"72","author":"Belyakov","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB10","first-page":"50","article-title":"Long-term non-progressor","volume":"vol. I","author":"Ho","year":"1994"},{"key":"10.1016\/j.clim.2004.04.001_BIB11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.clim.2004.04.001_BIB12","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.4049\/jimmunol.150.12.5647","article-title":"Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations","volume":"150","author":"Ahlers","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB13","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","article-title":"T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles","volume":"95","author":"Fehr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB14","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.4049\/jimmunol.145.12.4317","article-title":"Hepatitis B virus nucleocapsid\/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination","volume":"145","author":"Schodel","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-1119(91)90193-F","article-title":"Production of hepatitis B virion-like particles in yeast","volume":"106","author":"Shiosaki","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.clim.2004.04.001_BIB16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/JVI.66.1.106-114.1992","article-title":"The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity","volume":"66","author":"Schodel","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB17","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1128\/JVI.71.5.3365-3374.1997","article-title":"Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens","volume":"71","author":"Townsend","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/JVI.59.1.176-180.1986","article-title":"Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons","volume":"59","author":"Miyanohara","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","author":"Milich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.clim.2004.04.001_BIB20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.clim.2004.04.001_BIB21","first-page":"225","article-title":"Expression of HIV gag and env B-cell epitopes on the surface of HBV core particles and analysis of the immune responses generated to those epitopes","volume":"vol. 90","author":"Moriarty","year":"1990"},{"key":"10.1016\/j.clim.2004.04.001_BIB22","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1073\/pnas.86.16.6283","article-title":"Immunogenicity of peptide fusions to hepatitis B virus core antigen","volume":"86","author":"Stahl","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-5793(89)81509-1","article-title":"Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface","volume":"259","author":"Borisova","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clim.2004.04.001_BIB24","first-page":"193","article-title":"Recombinant HBV core particles carrying immunodominant B-cell epitopes of the HBV pre-S2 region","volume":"vol. 90","author":"Schodel","year":"1990"},{"key":"10.1016\/j.clim.2004.04.001_BIB25","first-page":"319","article-title":"Hybrid hepatitis B virus core\/PreS particles expressed in live attenuated Salmonellae for oral immunization","volume":"vol. 91","author":"Schodel","year":"1991"},{"key":"10.1016\/j.clim.2004.04.001_BIB26","first-page":"313","article-title":"Expression and immunologic analysis of hepatitis-B core fusion particles carrying internal heterologous sequences","volume":"vol. 91","author":"Clarke","year":"1991"},{"key":"10.1016\/j.clim.2004.04.001_BIB27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intimm\/4.2.283","article-title":"Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120","volume":"4","author":"Boudet","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB28","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.85.9.3105","article-title":"An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes","volume":"85","author":"Takahashi","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/31359","article-title":"HIV. Envelope's letters boxed into shape","volume":"393","author":"Moore","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2004.04.001_BIB30","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1126\/science.280.5371.1949","article-title":"A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.clim.2004.04.001_BIB31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/31514","article-title":"The antigenic structure of the HIV gp120 envelope glycoprotein","volume":"393","author":"Wyatt","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2004.04.001_BIB32","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/00002030-199813000-00005","article-title":"Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection","volume":"12","author":"Carotenuto","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.clim.2004.04.001_BIB33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/514111","article-title":"Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors","volume":"176","author":"Zhang","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2004.04.001_BIB34","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/JVI.61.11.3543-3549.1987","article-title":"Expression of hepatitis B virus middle and large surface antigen genes in Saccharomyces cerevisiae","volume":"61","author":"Imamura","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB35","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.62.6.2107-2114.1988","article-title":"Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope","volume":"62","author":"Matsushita","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB36","first-page":"69","article-title":"In SCID-hu mice, passive transfer of a humanized antibody prevents infection and atrophic change of medulla in human thymic implant due to intravenous inoculation of primary HIV-1 isolate","volume":"160","author":"Okamoto","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB37","first-page":"127","article-title":"Protein modified liposomes (HVJ-liposomes) for the delivery of genes, oligonucleotides and protein","volume":"vol. 4","author":"Saeki","year":"1998"},{"key":"10.1016\/j.clim.2004.04.001_BIB38","first-page":"50","article-title":"Virus (sendai virus envelopes) mediated gene transfer","volume":"vol. 3","author":"Kaneda","year":"1994"},{"key":"10.1016\/j.clim.2004.04.001_BIB39","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1089\/hum.1997.8.17-2133","article-title":"Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus); reciprocal effect of cationic lipid for in vitro and in vivo gene transfer","volume":"8","author":"Saeki","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.clim.2004.04.001_BIB40","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.4049\/jimmunol.167.10.5862","article-title":"HIV mucosal vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions","volume":"167","author":"Hiroi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1126\/science.2789433","article-title":"A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160","volume":"246","author":"Takahashi","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.clim.2004.04.001_BIB42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1084\/jem.183.3.879","article-title":"Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?","volume":"183","author":"Takahashi","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2004.04.001_BIB43","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1073\/pnas.92.23.10693","article-title":"Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals","volume":"92","author":"Honda","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB44","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.135.3.1834","article-title":"Characterization and partial purification of a specific interleukin 2 inhibitor","volume":"135","author":"Honda","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB45","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.148.7.2175","article-title":"Human soluble IL-6 receptor: its detection and enhanced release by HIV infection","volume":"148","author":"Honda","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB46","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.68.12.8312-8320.1994","article-title":"Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1","volume":"68","author":"Gorny","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.170.1.495","article-title":"HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses","volume":"170","author":"Sakaue","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.2911748","article-title":"Increased expression of DNA cointroduced with nuclear protein in adult rat liver","volume":"243","author":"Kaneda","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.clim.2004.04.001_BIB49","doi-asserted-by":"crossref","first-page":"27099","DOI":"10.1074\/jbc.272.43.27099","article-title":"Efficient transfer of synthetic ribozymes into cells using hemagglutinating virus of Japan (HVJ)-cationic liposomes. Application for ribozymes that target human t-cell leukemia virus type I tax\/rex mRNA","volume":"272","author":"Kitajima","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2004.04.001_BIB50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0042-6822(78)90116-2","article-title":"The mechanism of interferon induction in mouse spleen cells stimulated with HVJ","volume":"88","author":"Ito","year":"1978","journal-title":"Virology"},{"key":"10.1016\/j.clim.2004.04.001_BIB51","first-page":"175","article-title":"Simultaneous production of natural human tumor necrosi factor-alpha, -beta and interferon-alpha from BALL-1 cells stimulate by HVJ","volume":"7","author":"Fukuda","year":"1988","journal-title":"Lymphokine Res. Summer"},{"key":"10.1016\/j.clim.2004.04.001_BIB52","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.4049\/jimmunol.162.12.7322","article-title":"Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway","volume":"162","author":"Pirhonen","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB53","doi-asserted-by":"crossref","first-page":"13962","DOI":"10.1073\/pnas.96.24.13962","article-title":"IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils","volume":"96","author":"Yoshimoto","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2004.04.001_BIB54","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.4049\/jimmunol.161.9.5054","article-title":"Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels","volume":"161","author":"Hofstra","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB55","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.188.8.1485","article-title":"Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells","volume":"188","author":"Xu","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2004.04.001_BIB56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(75)92130-3","article-title":"Formation of virosomes from influenza subunits and liposomes","volume":"2","author":"Almeida","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2004.04.001_BIB57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.152.2.549","article-title":"Helper-CTL determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs","volume":"152","author":"Shirai","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0008-8749(92)90140-K","article-title":"Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct","volume":"141","author":"Lasarte","year":"1992","journal-title":"Cell Immunol."},{"key":"10.1016\/j.clim.2004.04.001_BIB59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-1759(92)90275-X","article-title":"T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides","volume":"155","author":"Widemann","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2004.04.001_BIB60","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2004.04.001_BIB61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199902040-00006","article-title":"Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy","volume":"13","author":"Martinon","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.clim.2004.04.001_BIB62","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1128\/JVI.72.12.10180-10188.1998","article-title":"Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus","volume":"72","author":"Kent","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB63","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1128\/JVI.73.8.6430-6435.1999","article-title":"Both memory and CD45RA+\/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals","volume":"73","author":"Ostrowski","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2004.04.001_BIB64","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661604001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661604001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T19:37:47Z","timestamp":1682710667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661604001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1521661604001172"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2004.04.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}